Anticancer Research is an international print and online monthly journal designed to rapidly publish peer-reviewed original works and reviews on all aspects of experimental and clinical cancer research.
Impact factor (2021): 2.435Current issue contents >>
In Vivo is an international online and open-access journal designed to bring together peer-reviewed original works and reviews on experimental and clinical biomedical research within the frames of human physiology, pathology and disease management.
Impact factor (2021): 2.406Current issue contents >>
Cancer Genomics & Proteomics
Cancer Genomics & Proteomics is an international peer-reviewed online and open-access journal designed to rapidly publish high quality articles and reviews on the application of genomic and proteomic technology to experimental and clinical cancer research.
Impact factor (2021): 3.395Current issue contents >>
Cancer Diagnosis & Prognosis
Cancer Diagnosis & Prognosis is an international online open-access peer-reviewed journal, designed to rapidly publish original and review papers on experimental and clinical research advancing the knowledge on the diagnosis and prognosis of all types of cancer, leukemia and metastasis.
Special Issue on Emerging Technologies in Cancer Research
High-throughput genomic technologies continuously advance and offer new opportunities to better understand and treat cancer. The past decade has seen a plethora of next-generation sequencing and data analysis studies, allowing us to map the genomic landscapes of various cancer types, while single cell analyses are shedding light on tumor heterogeneity. Groundbreaking new technologies, such as spatial omics, can give us unprecedented insight into the spatiotemporal tumor architecture and micro-environment. In this regard, this special issue aims to bring together review articles, experimental and clinical studies on the following topics:
– Whole-genome sequencing
– Single-cell genomics
– Mutational signatures
– Spatial transcriptomics
– Tumor architecture
– Tumor progression
– Data analysis methods / bioinformatics /machine learning
– Tumor heterogeneity
– Circulating tumor cells
– Precision medicine
– Tumor microenvironment interactions
– Computational immunology
– New therapeutic targets
Publication date: December 1, 2023; Submission deadline: November 3, 2023.
Instructions for the preparation and submission of reviews and original articles.
Anticancer Research, In Vivo, Cancer Genomics & Proteomics, and Cancer Diagnosis & Prognosis are independent international journals, published by the International Institute of Anticancer Research (IIAR), and have had no relation or association with other publishers since their establishment.
At the IIAR, we are committed to maintaining the highest content quality and the most rapid processing of submitted articles to our four journals.
All submitted articles are peer-reviewed to secure a valid assessment. Our preliminary review includes a detailed assessment of the suitability and validity of the conclusions of all cited references.
We value the support of our policy by our Authors and Readers and we look forward to receiving comments and suggestions for the
continuous improvement of our services.
Now you can access the entire contents of the IIAR journals published from 2013 till today
with ease on your Android© or iOS phone or tablet with our newly designed app, freely available on Google Play Store and App Store
Articles in ANTICANCER RESEARCH are fully available to everyone as open access 2 years after publication.
IN VIVO (from January 2017) and CANCER GENOMICS & PROTEOMICS (from January 2013) are published online-only with open access.
CANCER DIAGNOSIS & PROGNOSIS (from March 2021) is published online-only with open access.
Should you come across any errors in this website, please inform: firstname.lastname@example.org